PPARγ/NF‐κB and TGF‐β1/Smad pathway are involved in the anti‐fibrotic effects of levo‐tetrahydropalmatine on liver fibrosis

Liver fibrosis is a necessary stage in the development of chronic liver diseases to liver cirrhosis. This study aims to investigate the anti‐fibrotic effects of levo‐tetrahydropalmatine (L‐THP) on hepatic fibrosis in mice and cell models and its underlying mechanisms. Two mouse hepatic fibrosis mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qiang, Cheng, Ping, Wu, Jianye, Guo, Chuanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875896/
https://www.ncbi.nlm.nih.gov/pubmed/33438347
http://dx.doi.org/10.1111/jcmm.16267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875896/
https://www.ncbi.nlm.nih.gov/pubmed/33438347
http://dx.doi.org/10.1111/jcmm.16267

Ejemplares similares